Population-based Risk Factors for Elevated Alanine Aminotransferase in a South Texas Mexican-American Population

Archives of Medical Research

Volumn 43, Issue 6, 2012, Pages 482-488

  Qu, Hui Qi ^a   Li, Quan ^b   Grove, Megan L ^a   Lu, Yang ^a   Pan, Jen Jung ^c   Rentfro, Anne R ^d   Bickel, Perry E ^c   Fallon, Michael B ^c   Hanis, Craig L ^a   Boerwinkle, Eric ^a   McCormick, Joseph B ^a   Fisher Hoch, Susan P ^a  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS AT BROWNSVILLE   (United States)

Author keywords

Alanine aminotransferase; Liver disease; Machine learning; NAFLD; PNPLA3 polymorphism; Public health

Indexed keywords

ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER; INSULIN; MECASERMIN RINFABATE; PNPLA3 PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BAYESIAN LEARNING; BODY MASS; BODY WEIGHT; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GENETIC MARKER; GENOTYPE; HISPANIC; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; POPULATION RESEARCH; POPULATION RISK; PREDICTOR VARIABLE; PREVALENCE; SUPPORT VECTOR MACHINE; TRIACYLGLYCEROL BLOOD LEVEL;

ALANINE TRANSAMINASE; FEMALE; HUMANS; MALE; MEXICAN AMERICANS; RISK FACTORS; SUPPORT VECTOR MACHINES; TEXAS;

EID: 84867860306     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2012.08.005     Document Type: Article

References (33)

1. Perez A., Anzaldua M., McCormick J., et al. High frequency of chronic end-stage liver disease and hepatocellular carcinoma in a Hispanic population. J Gastroenterol Hepatol 2004, 19:289-295.
2. Fisher-Hoch S.P., Rentfro A.R., Salinas J.J., et al. Socioeconomic status and prevalence of obesity and diabetes in a Mexican American community, Cameron County, Texas, 2004-2007. Prev Chronic Dis 2010, 7:A53.
3. Qu H.Q., Li Q., Rentfro A.R., et al. The definition of insulin resistance using HOMA-IR for Americans of Mexican descent using machine learning. PLoS One 2011, 6:e21041.
4. Pan J.J., Qu H.Q., Rentfro A., et al. Prevalence of metabolic syndrome and risks of abnormal serum alanine aminotransferase in Hispanics: a population-based study. PLoS One 2011, 6:e21515.
5. Salinas J., McCormick J.B., Rentfro A., et al. The missing men: high risk of disease in men of Mexican origin. Am J Mens Health 2011, 5:332-340.
6. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33:S62-S69. American Diabetes Association.
7. Romeo S., Kozlitina J., Xing C., et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008, 40:1461-1465.
8. Chalasani N., Guo X., Loomba R., et al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology 2010, 139:1567-1576. 1576 e1561-1566.
9. Yuan X., Waterworth D., Perry J.R.B., et al. Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Human Genet 2008, 83:520-528.
10. Cortes C., Vapnik V. Support-vector networks. Machine Learning 1995, 20:273-297.
11. Noble W.S. What is a support vector machine?. Nat Biotechnol 2006, 24:1565-1567.
12. Wei Z., Wang K., Qu H.Q., et al. From disease association to risk assessment: an optimistic view from genome-wide association studies on type 1 diabetes. PLoS Genet 2009, 5:e1000678.
13. Clark T.G., De Iorio M., Griffiths R.C. Bayesian logistic regression using a perfect phylogeny. Biostatistics 2007, 8:32-52.
14. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
15. Fan R.-E., Chen P.-H., Lin C.-J. Working set selection using second order information for training support vector machines. J Mach Learn Res 2005, 6:1889-1918.
16. Chen Y.W., Lin C.J. Combining SVMs with various feature selection strategies. Feature Extraction, Foundations and Applications 2006, Springer, New York.
17. Oh S.Y., Cho Y.K., Kang M.S., et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 2006, 55:1604-1609.
18. Bedogni G., Miglioli L., Masutti F., et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005, 42:44-52.
19. Falck-Ytter Y., Younossi Z.M., Marchesini G., et al. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001, 21:17-26.
20. Tilg H. Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosis. Curr Pharm Des 2010, 16:1893-1895.
21. Sanyal D., Mukhopadhyay P., Pandit K., et al. Central obesity but not generalised obesity (body mass index) predicts high prevalence of fatty liver (NRFLD), in recently detected untreated, IGT and type 2 diabetes Indian subjects. J Indian Med Assoc 2009, 107:755-758.
22. Polyzos S.A., Kountouras J., Zavos C. Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines. Curr Mol Med 2009, 9:299-314.
23. Vanni E., Bugianesi E. The gut-liver axis in nonalcoholic fatty liver disease: another pathway to insulin resistance?. Hepatology 2009, 49:1790-1792.
24. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J Clin Investig 2006, 116:1793-1801.
25. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
26. Assy N., Kaita K., Mymin D., et al. Fatty infiltration of liver in hyperlipidemic patients. Dig Dis Sci 2000, 45:1929-1934.
27. Hashimoto E., Tokushige K. Prevalence, gender, ethnic variations, and prognosis of NASH. J Gastroenterol 2011, 46(suppl 1):S63-S69.
28. Christensen K.E., Wu Q., Wang X., et al. Steatosis in mice is associated with gender, folate intake, and expression of genes of one-carbon metabolism. J Nutr 2010, 140:1736-1741.
29. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
30. Arsenault B.J., Boekholdt S.M., Kastelein J.J. Lipid parameters for measuring risk of cardiovascular disease. Nat Rev Cardiol 2011, 8:197-206.
31. Sookoian S., Pirola C.J. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 2011, 53:1883-1894.
32. Myers R.P. Noninvasive diagnosis of nonalcoholic fatty liver disease. Ann Hepatol 2009, 8(suppl 1):S25-S33.
33. Bravo A.A., Sheth S.G., Chopra S. Liver biopsy. N Engl J Med 2001, 344:495-500.